CS Diagnostics Corp. (CSDX)

Market Cap	7.25M -73.6%
Revenue (ttm)	204.00K +83.9%
Net Income	71.22K +9,258.6%
EPS	0.00 +5,580.0%
Shares Out	249.99M
PE Ratio	102.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.0700
Previous Close	0.0290
Day's Range	0.0290 - 0.0700
52-Week Range	0.0085 - 0.4000
Beta	-21.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About CS Diagnostics

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSDX

Financial Performance

In 2025, CS Diagnostics's revenue was $204,000, an increase of 83.93% compared to the previous year's $110,911. Earnings were $71,219, an increase of 9258.61%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error